Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7489

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907489)

FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)
This excerpt appears to be a statistical analysis related to a clinical trial comparing the effects of RSV (assumed to be respiratory syncytial virus) treatment versus placebo, potentially with the addition of rosuvastatin medication. The data includes hazard ratio (HR) results, confidence intervals, and numbers at risk over a period of 5 years. The HR of 0.56 with a statistically significant p-value (<0.001) suggests a potential difference in outcomes between the treatment groups.*
FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)
This is a statistical analysis table comparing the impact of Roswa20mg and Placebo20mg on various cardiovascular events, including primary endpoints, cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and revascularization. The table includes the number of events, hazard ratios, confidence intervals, and p-values. It also provides event rates per 1000-patient years and specifies that cardiovascular death encompasses fatal MI, fatal stroke, sudden death, and other adjudicated causes of CV death.*
FDA Label Image

Figure 3. (Rosuvastatin Fig3)

Figure 3. (Rosuvastatin Fig3)
This text presents the percent change from baseline in LDL-C levels for different doses of four types of statin drugs: rosuvastatin, atorvastatin, simvastatin, and pravastatin. The doses evaluated for each drug are in milligrams (mg). The text provides a comparison of the percent change data for each drug at doses of 10, 20, and 40 mg, with some higher doses included for atorvastatin and simvastatin. This information can be useful for understanding the impact of different statin drugs at various doses on LDL cholesterol levels.*
FDA Label Image

Chemical Structure (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.